U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H25N5O
Molecular Weight 327.424
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-987306

SMILES

[H][C@@]12CCCC[C@]1([H])C3=C(CCC4=C(N=C(N)N=C34)N5CCNCC5)O2

InChI

InChIKey=DJKJVWJQAVGLHJ-WCQYABFASA-N
InChI=1S/C18H25N5O/c19-18-21-16-12(17(22-18)23-9-7-20-8-10-23)5-6-14-15(16)11-3-1-2-4-13(11)24-14/h11,13,20H,1-10H2,(H2,19,21,22)/t11-,13+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H25N5O
Molecular Weight 327.424
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including http://www.fasebj.org/content/23/1_Supplement/760.8.short

A-987306 is a new histamine H(4) antagonist. A-987306 is potent in H(4) receptor binding assays (rat H(4), K(i) = 3.4 nM, human H(4) K(i) = 5.8 nM) and demonstrated potent functional antagonism in vitro at human, rat, and mouse H(4) receptors in cell-based FLIPR assays. A-987306 also demonstrated H(4) antagonism in vivo in mice, blocking H(4)-agonist induced scratch responses, and showed anti-inflammatory activity in mice in a peritonitis model. Most interesting was the high potency and efficacy of this compound in blocking pain responses, where it showed an ED(50) of 42 umol/kg (ip) in a rat post-carrageenan thermal hyperalgesia model of inflammatory pain. A-987306 inhibited the scratching response (IC50 = 0.4 umoles/kg, i.p.) with (85%) inhibition seen at 30 umoles/kg, i.p. A-987306 is a potent and selective H4R antagonist with robust antipruritic activity and is a useful tool for further exploration of the role of H4R receptors in vivo.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
2008 Nov 27
Patents

Sample Use Guides

30 umoles/kg, i.p.
Route of Administration: Intraperitoneal
A-987306 competitively and potently antagonize rat H4R agonist-mediated responses in [35S]GTPγS binding assays (Kbs = 6 nM) and intracellular calcium mobilization at rat and human receptors (Kbs from 5-10 nM).
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:57:40 GMT 2023
Edited
by admin
on Sat Dec 16 10:57:40 GMT 2023
Record UNII
6BVK16R925
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
A-987306
Common Name English
BENZOFURO(2,3-H)QUINAZOLIN-2-AMINE, 5,6,7A,8,9,10,11,11A-OCTAHYDRO-4-(1-PIPERAZINYL)-, (7AR,11AR)-REL-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID70148488
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
PUBCHEM
44538833
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
CAS
1082954-71-9
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
FDA UNII
6BVK16R925
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY